U.S. Biosensors Market Size, Share & Trends Analysis Report By Technology (Electrochemical, Thermal, Piezoelectric), By Application (Medical, Food Toxicity, Bioreactor), By End-use, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
U.S. Biosensors Market Growth & Trends
The U.S. biosensors market size is anticipated to reach USD 15.61 billion by 2030 and is projected to grow at a CAGR of 7.13% from 2024 to 2030, according to a new report by Grand View Research, Inc. It encompasses various biosensor devices, components, technologies, and services used across multiple industries, such as healthcare, food safety, environmental monitoring, agriculture, biotechnology, and security.
The U.S. market is experiencing significant growth driven by a combination of factors. One key driver is the increasing demand for point-of-care testing (POCT) solutions, which offer rapid and convenient diagnostic capabilities outside of traditional laboratory settings.
Biosensors play a crucial role in diagnosing, monitoring, and managing these conditions, driving demand for innovative biosensor solutions. Regulatory support and approvals for biosensor technologies and a growing emphasis on personalized medicine are also contributing to market expansion. For instance, the FoundationOne CDx test, approved by the FDA, is a companion diagnostic utilizing next-generation sequencing to detect advanced cancer patients who could potentially benefit from targeted therapies. The test uses biosensors to examine tumor DNA to provide details on actionable genomic alterations.
U.S. Biosensors Market Report Highlights
U.S. Biosensors Market Growth & Trends
The U.S. biosensors market size is anticipated to reach USD 15.61 billion by 2030 and is projected to grow at a CAGR of 7.13% from 2024 to 2030, according to a new report by Grand View Research, Inc. It encompasses various biosensor devices, components, technologies, and services used across multiple industries, such as healthcare, food safety, environmental monitoring, agriculture, biotechnology, and security.
The U.S. market is experiencing significant growth driven by a combination of factors. One key driver is the increasing demand for point-of-care testing (POCT) solutions, which offer rapid and convenient diagnostic capabilities outside of traditional laboratory settings.
Biosensors play a crucial role in diagnosing, monitoring, and managing these conditions, driving demand for innovative biosensor solutions. Regulatory support and approvals for biosensor technologies and a growing emphasis on personalized medicine are also contributing to market expansion. For instance, the FoundationOne CDx test, approved by the FDA, is a companion diagnostic utilizing next-generation sequencing to detect advanced cancer patients who could potentially benefit from targeted therapies. The test uses biosensors to examine tumor DNA to provide details on actionable genomic alterations.
U.S. Biosensors Market Report Highlights
- Based on technology, the electrochemical segment led the market with the largest revenue share of 72.86% in 2023, due to its diverse use across various sectors and industries, these biosensors can be miniaturized and integrated into portable devices such as personal glucose meter that provides fast measurement of blood glucose levels for personal glycemic management
- Based on application, the medical segment led the market with the largest revenue share of 65.57%in 2023, due to the rapid and accurate diagnostic tools, emphasis on personalized medicine, advancements in healthcare technology, and others. For instance, in November 2021, Quanterix, a U.S.-based company specializing in digital biomarker solutions, announced the release of its Simoa Ultra-Sensitive Biosensors Platform. This platform empowers the detection of low-abundance biomarkers associated with various diseases
- Based on end-use, the point of care (PoC) testing segment led the market with the largest revenue share of 47.67% in 2023, due to their demand in various settings including clinics, pharmacies, and emergency departments
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Technology
1.2.2. Application
1.2.3. End-use
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.3. Competitive Insights
CHAPTER 3. U.S. BIOSENSORS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. U.S. Biosensors Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.2.4. Social landscape
3.3.2.5. Legal landscape
3.3.2.6. Environmental landscape
CHAPTER 4. U.S. BIOSENSORS MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
4.1. Technology Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. biosensors market By Technology Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Thermal
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Electrochemical
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Piezoelectric
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Optical
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. U.S. BIOSENSORS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Product Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. biosensors market By Application Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Medical
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Food Toxicity
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Bioreactor
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Agriculture
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.5. Environment
5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.6. Others
5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. U.S. BIOSENSORS MARKET: END-USE ESTIMATES & TREND ANALYSIS
6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. U.S. Biosensors Market By End-use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Home healthcare diagnostics
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. PoC testing
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Food industry
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.4. Research Laboratories
6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.5. Security and Bio-defense
6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. U.S. BIOSENSORS MARKET: REGION ESTIMATES & TREND ANALYSIS
7.1. Regional Market Share, 2023 & 2030
7.2. U.S. Biosensors Market by Region Outlook
7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
7.3.1. West
7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.2. Midwest
7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.3. Northeast
7.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.4. Southwest
7.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.5. Southeast
7.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company heat map analysis, 2023
8.4. Company Profiles
8.4.1. Abbott
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Medtronic
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Hoffmann-La Roche Ltd
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Dexcom, Inc.
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. SENTINEL
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Intricon Corporation
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Quanterix
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Koninklijke Philips N.V.
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Masimo
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Siemens Healthcare Private Limited
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
8.4.11. Molecular Devices, LLC.
8.4.11.1. Company overview
8.4.11.2. Financial performance
8.4.11.3. Product benchmarking
8.4.11.4. Strategic initiatives
8.4.12. Johnson & Johnson Services, Inc.
8.4.12.1. Company overview
8.4.12.2. Financial performance
8.4.12.3. Product benchmarking
8.4.12.4. Strategic initiatives
8.4.13. Thermo Fisher Scientific Inc.
8.4.13.1. Company overview
8.4.13.2. Financial performance
8.4.13.3. Product benchmarking
8.4.13.4. Strategic initiatives
8.4.14. PerkinElmer Inc.
8.4.14.1. Company overview
8.4.14.2. Financial performance
8.4.14.3. Product benchmarking
8.4.14.4. Strategic initiatives
8.4.15. Covaris, LLC
8.4.15.1. Company overview
8.4.15.2. Financial performance
8.4.15.3. Product benchmarking
8.4.15.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Technology
1.2.2. Application
1.2.3. End-use
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.3. Competitive Insights
CHAPTER 3. U.S. BIOSENSORS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. U.S. Biosensors Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.2.4. Social landscape
3.3.2.5. Legal landscape
3.3.2.6. Environmental landscape
CHAPTER 4. U.S. BIOSENSORS MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
4.1. Technology Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. biosensors market By Technology Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Thermal
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Electrochemical
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Piezoelectric
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Optical
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. U.S. BIOSENSORS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Product Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. biosensors market By Application Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Medical
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Food Toxicity
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Bioreactor
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Agriculture
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.5. Environment
5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.6. Others
5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. U.S. BIOSENSORS MARKET: END-USE ESTIMATES & TREND ANALYSIS
6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. U.S. Biosensors Market By End-use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Home healthcare diagnostics
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. PoC testing
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Food industry
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.4. Research Laboratories
6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.5. Security and Bio-defense
6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. U.S. BIOSENSORS MARKET: REGION ESTIMATES & TREND ANALYSIS
7.1. Regional Market Share, 2023 & 2030
7.2. U.S. Biosensors Market by Region Outlook
7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
7.3.1. West
7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.2. Midwest
7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.3. Northeast
7.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.4. Southwest
7.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.5. Southeast
7.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company heat map analysis, 2023
8.4. Company Profiles
8.4.1. Abbott
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Medtronic
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Hoffmann-La Roche Ltd
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Dexcom, Inc.
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. SENTINEL
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Intricon Corporation
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Quanterix
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Koninklijke Philips N.V.
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Masimo
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Siemens Healthcare Private Limited
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
8.4.11. Molecular Devices, LLC.
8.4.11.1. Company overview
8.4.11.2. Financial performance
8.4.11.3. Product benchmarking
8.4.11.4. Strategic initiatives
8.4.12. Johnson & Johnson Services, Inc.
8.4.12.1. Company overview
8.4.12.2. Financial performance
8.4.12.3. Product benchmarking
8.4.12.4. Strategic initiatives
8.4.13. Thermo Fisher Scientific Inc.
8.4.13.1. Company overview
8.4.13.2. Financial performance
8.4.13.3. Product benchmarking
8.4.13.4. Strategic initiatives
8.4.14. PerkinElmer Inc.
8.4.14.1. Company overview
8.4.14.2. Financial performance
8.4.14.3. Product benchmarking
8.4.14.4. Strategic initiatives
8.4.15. Covaris, LLC
8.4.15.1. Company overview
8.4.15.2. Financial performance
8.4.15.3. Product benchmarking
8.4.15.4. Strategic initiatives
LIST OF TABLES
Table 1 List of abbreviations
Table 2 U.S. biosensors market, by technology, 2018 - 2030 (USD Million and Volume Unit)
Table 3 U.S. biosensors market, by application, 2018 - 2030 (USD Million and Volume Unit)
Table 4 U.S. biosensors market, by end-use, 2018 - 2030 (USD Million and Volume Unit)
Table 5 U.S. biosensors market, by region, 2018 - 2030 (USD Million and Volume Unit)
Table 1 List of abbreviations
Table 2 U.S. biosensors market, by technology, 2018 - 2030 (USD Million and Volume Unit)
Table 3 U.S. biosensors market, by application, 2018 - 2030 (USD Million and Volume Unit)
Table 4 U.S. biosensors market, by end-use, 2018 - 2030 (USD Million and Volume Unit)
Table 5 U.S. biosensors market, by region, 2018 - 2030 (USD Million and Volume Unit)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. biosensors market: Market outlook
Fig. 9 U.S. clinical trial supplies competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 U.S. biosensors market driver impact
Fig. 14 U.S. biosensors market restraint impact
Fig. 15 U.S. biosensors market: Technology movement analysis
Fig. 16 U.S. biosensors market: Technology outlook and key takeaways
Fig. 17 Thermal market estimates and forecast, 2018 - 2030 (USD Million and Volume Unit)
Fig. 18 Electrochemical market estimates and forecast, 2018 - 2030 (USD Million and Volume Unit)
Fig. 19 Piezoelectric market estimates and forecast, 2018 - 2030 (USD Million and Volume Unit)
Fig. 20 Optical market estimates and forecast, 2018 - 2030 (USD Million and Volume Unit)
Fig. 21 U.S. biosensors market: Application movement Analysis
Fig. 22 U.S. biosensors market: Application outlook and key takeaways
Fig. 23 Medical market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 24 Food toxicity market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 25 Bioreactor market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 26 Agriculture market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 27 Environment market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 28 Others market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 29 U.S. biosensors market: End-use movement analysis
Fig. 30 U.S. biosensors market: End-use outlook and key takeaways
Fig. 31 Home healthcare diagnostics market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 32 PoC Testing market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 33 Food industry market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 34 Research laboratories market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 35 Security and bio-defense market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 36 U.S. pediatric home healthcare market: Regional movement analysis
Fig. 37 U.S. pediatric home healthcare market: Regional outlook and key takeaways
Fig. 38 West market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 39 Midwest market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 40 Northeast market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 41 Southwest market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 42 Southeast market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. biosensors market: Market outlook
Fig. 9 U.S. clinical trial supplies competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 U.S. biosensors market driver impact
Fig. 14 U.S. biosensors market restraint impact
Fig. 15 U.S. biosensors market: Technology movement analysis
Fig. 16 U.S. biosensors market: Technology outlook and key takeaways
Fig. 17 Thermal market estimates and forecast, 2018 - 2030 (USD Million and Volume Unit)
Fig. 18 Electrochemical market estimates and forecast, 2018 - 2030 (USD Million and Volume Unit)
Fig. 19 Piezoelectric market estimates and forecast, 2018 - 2030 (USD Million and Volume Unit)
Fig. 20 Optical market estimates and forecast, 2018 - 2030 (USD Million and Volume Unit)
Fig. 21 U.S. biosensors market: Application movement Analysis
Fig. 22 U.S. biosensors market: Application outlook and key takeaways
Fig. 23 Medical market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 24 Food toxicity market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 25 Bioreactor market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 26 Agriculture market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 27 Environment market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 28 Others market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 29 U.S. biosensors market: End-use movement analysis
Fig. 30 U.S. biosensors market: End-use outlook and key takeaways
Fig. 31 Home healthcare diagnostics market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 32 PoC Testing market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 33 Food industry market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 34 Research laboratories market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 35 Security and bio-defense market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 36 U.S. pediatric home healthcare market: Regional movement analysis
Fig. 37 U.S. pediatric home healthcare market: Regional outlook and key takeaways
Fig. 38 West market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 39 Midwest market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 40 Northeast market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 41 Southwest market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
Fig. 42 Southeast market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
